Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,913 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

NCT03940586

Conditions
Cytomegalovirus (CMV) Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • City of Hope Comprehensive Cancer Center ( Site 0251) Duarte, California, United States
  • Children's Hospital of Orange County ( Site 0241) Orange, California, United States
  • UCSF Benioff Children's Hospital San Francisco ( Site 0245) San Francisco, California, United States
  • University Of Chicago School Of Medicine ( Site 0253) Chicago, Illinois, United States
View all 40 locations
View Trial Details
Completed

MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)

NCT04129398

Conditions
Cytomegalovirus Disease, Cytomegalovirus Infection, Cytomegalovirus Infections, +4 more
Locations
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital ( Site 0002) Nagoya, Aichi-ken, Japan
  • Sapporo City General Hospital ( Site 0004) Sapporo, Hokkaido, Japan
  • Osaka University Hospital ( Site 0003) Suita, Osaka, Japan
  • Tokyo Women's Medical University Hospital ( Site 0001) Tokyo, Japan
View Trial Details
Completed

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

NCT04450069

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV

NCT04778904

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Pusan National University Hospital Busan, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
  • Keimyung University Dongsan Hospital Daegu, South Korea
  • Yonsei University College of Medicine Seoul, South Korea
View Trial Details
Completed

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

NCT02595866

Conditions
AIDS-Related Non-Hodgkin Lymphoma, Adenocarcinoma, Blood-Borne Infections, +76 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis

NCT03934736

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +23 more
Locations
  • DaVita Clinical Research or Affiliate Bloomfield, Connecticut, United States
  • DaVita Clinical Research or Affiliate Middlebury, Connecticut, United States
  • DaVita Clinical Research or Affiliate Hollywood, Florida, United States
  • DaVita Clinical Research or Affiliate Ocala, Florida, United States
View all 20 locations
View Trial Details
Completed

Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection

NCT06544551

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
Locations
  • Beijing Ditan Hospital, Capital Medical University Beijing, China
  • Beijing Youan Hospital, Capital Medical University Beijing, China
  • Peking university Peoole's hospital Beijing, China
  • The First Hospital of Jilin University Changchun, China
View all 34 locations
View Trial Details

Related conditions